AQUA 2024

August 26 - 30, 2024

Copenhagen, Denmark

TARGETING THE OPTIMIZATION OF GUT MICROBIOTA-HOST INTERACTION IN SALMONS: ASSESSING FUNCTIONAL INGREDIENTS IN AN EX VIVO APPROACH

 Ana Teresa Gonçalves*1,2, Hugo Pereira2, Rui Rocha3 , Soraia Santos2, Luis Conceição1, Jorge Dias1

1SPAROS, Lda., Área Empresarial de Marim Lote C 8700-221 Olhão, Portugal

2GreenCoLab – Universidade do Algarve, Campus de Gambelas Ed. 2, Gab2.1 8005-139 Faro, Portugal

anagoncalves@sparos.pt

 



The interface between microbiota and the host mucosal functioning is a stage for numerous processes that are key for the host s´  defensive system. In aquaculture, opportunistic microorganisms are often harbored in mucosal systems, causing disease outbreaks when fish homeostasis is disrupted. The modulation of this interface by targeting undesirable bacteria is a strategy that has been tested through nutritional approaches, such as the inclusion of functional ingredients like prebiotics. In salmon aquaculture, mucosal health and well-functioning  are among the most important topics, and the implementation of novel strategies is needed to support the welfare  and boost the resistance of fish. In this study, we assess the modulation of the gut mucosa microbiota and its function in two different intestinal compartments ( proximal and middle intestine) by including  the  microalgae  Euglena gracilis , with potential prebiotic effects in an ex vivo intestinal sac platform. The modulation of targeted microbial groups with opportunistic (e.g., Vibrio , Aeromonas , Tenacibaculum )  or beneficial (e.g., Lactobacillus , Bacillus) characteristics was screened through Nanopore MinION 16S long-read bacteriome sequencing and compared between  the  compartments’ mucosa exposed to an antibiotic treatment, or unexposed .  An in-house bioinformatic pipeline was applied to retrieve the relative abundance of bacterial pathogens based on  an  aquaculture bacterial pathogen database with  in-house modifications, and an in-house database of bacteria with reported beneficial impacts was used for comparison purposes . Moreover , the mucosa response was assessed and correlated with microbiota shifts  following the transcriptional  modulation of a panel of genes related  to immune response, epithelium integrity, and  homeostasis. Among all the identified potentially pathogenic bacteria, a group was affected by the exposure of the intestinal mucosa to microalgae, and some beneficial bacteria were also affected . The ratios Firmicutes:Bacteroidetes , and Proteobacteria:Bacteroidetes were modulated, increasing when mucosa was exposed to  an  antibiotic. This was evident in both compartments, and the opposite was observed when microalgae were included in the sac in one of the compartments. The expression of the acute inflammation markers indicated an impact on the mucosas´ health. Th rough the application of an ex vivo approach, it was possible to screen and highlight  the impacts of a  harmful compound and an algae-based functional ingredient.

 Acknowledgments: This work was financially supported by the project MICROBOOST – PT-INNOVATION-0102 – funded by Iceland, Liechtenstein and Norway through the European Economic Area (EEA) grants